New hope for lymphoma patients in early drug trial
NCT ID NCT03985189
First seen Jan 07, 2026 · Last updated May 22, 2026 · Updated 20 times
Summary
This early-stage study tested a new drug called ME-401 in 14 Japanese adults with a slow-growing blood cancer (indolent B-cell non-Hodgkin's lymphoma) that had come back or stopped responding to treatment. The main goal was to check the drug's safety and how the body processes it. Participants had not used a similar type of drug (PI3K inhibitor) before.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY INDOLENT B-CELL NON-HODGKIN'S LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Aomori Prefectural Central Hospital
Aomori, 030-8553, Japan
-
Hokkaido University Hospital
Sapporo, Hokkaido, 060-0814, Japan
-
Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital
Nagoya, Aichi-ken, 466-8650, Japan
-
Kyushu University Hospital
Fukuoka, 812-8582, Japan
-
National Cancer Center Hospital
Chuo-ku, Tokyo, 104-0045, Japan
-
National Hospital Organization Nagoya Medical Center
Nagoya, Aichi-ken, 460-0001, Japan
-
Okayama University Hospital
Okayama, 700-8558, Japan
-
The Cancer Institute Hospital of JFCR
Koto-ku, Tokyo, 135-8550, Japan
-
Tokyo Metropolitan Komagome Hospital
Bunkyo-ku, Tokyo, 113-8677, Japan
Conditions
Explore the condition pages connected to this study.